Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages
- PMID: 37787149
- PMCID: PMC10987389
- DOI: 10.1093/inthealth/ihad087
Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages
Erratum in
-
Erratum to: Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages.Int Health. 2024 May 1;16(3):368. doi: 10.1093/inthealth/ihad113. Int Health. 2024. PMID: 38033316 No abstract available.
Abstract
Benzathine benzylpenicillin is a globally indispensable medicine. As a long-lasting injectable penicillin, it serves as the primary treatment for syphilis, group A streptococcal infections, rheumatic fever and rheumatic heart disease. A competitive market and low profit margins, compounded by limited visibility of demand, have resulted in a decreased number of active pharmaceutical ingredient (API) manufacturers. By 2016, only three Chinese API manufacturers remained, continuing to supply to the global market today. Recurring global shortages, a consequence of supply and demand imbalances, indicate underlying market risks. Therefore, the need for mitigation strategies is imperative.
Keywords: benzathine penicillin; drug manufacture; medication shortages; rheumatic heart disease; syphilis.
Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene 2023.
Conflict of interest statement
Comment on
-
Erratum to: Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages.Int Health. 2024 May 1;16(3):368. doi: 10.1093/inthealth/ihad113. Int Health. 2024. PMID: 38033316 No abstract available.
References
-
- Wyber R, Carapetis J. Evolution, evidence and effect of secondary prophylaxis against rheumatic fever. J Pract Cardiovasc Scie. 2015;1(1):9–14.
-
- World Health Organization. Guidelines for the treatment of Treponema pallidum (syphilis). Geneva: World Health Organization; 2016. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials